Position in VNDA
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$581,326
+$312,838 QoQ
Shares Held
94,988
+144.5% QoQ
Ownership
0.157%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#56
of 172 holders
Holding Since
Mar 2020
18 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in VNDA Over Time
Shares Held
Position Value (USD)
Derivatives in VNDA
reported options exposure · as of Jun 30, 2021CallValue
$0
CallShares
0
PutValue
$0
PutShares
400
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026HSBC HOLDINGS PLC holds $1,221,504,678 across 135 Biotechnology names. VNDA ranks #65 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
676,247 | $335,912,169 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
382,028 | $238,209,735 | |
| 3 | INCY |
Incyte Corp
|
1,307,743 | $148,245,744 | |
| 4 | RPRX |
Royalty Pharma plc
|
1,224,925 | $68,681,542 | |
| 5 | MRNA |
Moderna, Inc.
|
636,199 | $44,553,014 | |
| 6 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
115,279 | $34,702,435 | |
| 7 | INSM |
INSMED Inc
|
279,961 | $29,849,438 | |
| 8 | BMRN |
Biomarin Pharmaceutical Inc
|
307,543 | $17,597,610 |
All Filings in VNDA
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $581,326 | 94,988 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $268,488 | 38,855 | Shares | Defined | 2026-04-30 | |
| 2025-12-31 | $314,971 | 35,711 | Shares | Defined | 2026-03-06 | |
| 2025-09-30 | $355,517 | 71,246 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $314,134 | 66,554 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $259,766 | 56,594 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $230,154 | 48,049 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $124,120 | 26,465 | Shares | Defined | 2024-11-14 | |
| 2023-12-31 | $123,253 | 29,207 | Shares | Defined | 2024-02-12 | |
| 2022-12-31 | $77,949 | 10,548 | Shares | Defined | 2023-02-14 | |
| 2022-06-30 | $132,990 | 12,201 | Shares | Defined | 2022-08-11 | |
| 2022-03-31 | $151,429 | 13,389 | Shares | Defined | 2022-05-16 | |
| 2021-06-30 ALXN | — | 400 | Put | Defined | 2021-08-13 | |
| 2021-06-30 ALXN | — | 454,149 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 ALXN | — | 635,911 | Shares | Defined | 2021-05-14 | |
| 2021-03-31 ALXN | — | 400 | Put | Defined | 2021-05-14 | |
| 2020-12-31 ALXN | — | 373,677 | Shares | Sole | 2021-02-25 | |
| 2020-09-30 ALXN | — | 284,096 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 ALXN | — | 300,534 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 ALXN | — | 331,195 | Shares | Defined | 2020-05-15 | |
| 2020-03-31 ALXN | — | 400 | Call | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||